Počet záznamov: 1
epoprostenol
SYS d011464 LBL 00000cz--a2200000n--4500 005 20250606214404.4 008 920523|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D10.251.355.255.550.550.500 065 $a D23.469.050.175.725.550.500 066 $a 01 $c 03 150 $a epoprostenol $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Prostacyclin $2 eng 450 $w v $a Prostaglandin I2 $2 eng 450 $w v $a prostacyklín $2 slo 450 $w v $a prostaglandín I2 $2 slo 450 $w v $a epoprostenol sodný $2 slo 450 $w v $a epoprostanol $2 slo 550 $7 sllk_us_auth*d000959 $Y Antihypertensive Agents $w P $a antihypertenzíva 550 $7 sllk_us_auth*d010975 $Y Platelet Aggregation Inhibitors $w P $a inhibítory agregácie trombocytov 665 $a 1991 (1978); use PROSTAGLANDINS X 1978-1990; for PROSTACYCLIN use PROSTACYCLINS 1978-1993; for PROSTAGLANDIN I2 use PROSTAGLANDINS I2 1982-1993; for PROSTAGLANDIN X use PROSTAGLANDINS X 1991-1993 $2 eng 665 $a Prostaglandins (1966-1977) $2 eng 680 9-
$i A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). $2 eng 750 -2
$a Epoprostenol $2 eng 980 $x M
Počet záznamov: 1